GILEAD SCIENCES, INC. v. NATCO PHARMA LTD.

No. 2013-1418.

753 F.3d 1208 (2014)

GILEAD SCIENCES, INC., Hoffmann-La Roche, Inc., F. Hoffmann-La Roche, Ltd., and Genentech, Inc., Plaintiffs-Appellees, v. NATCO PHARMA LIMITED and Natco Pharma, Inc., Defendants-Appellants.

United States Court of Appeals, Federal Circuit.

April 22, 2014.


Attorney(s) appearing for the Case

Leora Ben-Ami , Kirkland & Ellis LLP, of New York, NY, argued for plaintiffs-appellees. With her on the brief were Patricia A. Carson and Benjamin A. Lasky.

Jeremy C. Lowe , Axinn, Veltrop & Harkrider LLP, of Hartford, Connecticut, argued for defendants-appellants. With him on the brief was Thomas K. Hedemann.

Opinion for the court filed by Circuit Judge CHEN. Dissenting opinion filed by Chief Judge RADER.


CHEN, Circuit Judge.

Gilead Sciences, Inc. ("Gilead") owns United States Patent Nos. 5,763,483 and 5,952,375, which are directed to antiviral compounds and methods for their use. While the patents list the same inventors and the written descriptions disclose similar content, they do not claim priority to a common patent application and have different expiration dates. Gilead sued Natco Pharma Limited ("Natco") for infringement of the '483 patent after Natco filed...

Let's get started

Leagle.com

Welcome to the leading source of independent legal reporting
Sign on now to see your case.
Or view more than 10 million decisions and orders.

  • Updated daily.
  • Uncompromising quality.
  • Complete, Accurate, Current.

Listed below are the cases that are cited in this Featured Case. Click the citation to see the full text of the cited case. Citations are also linked in the body of the Featured Case.

Cited Cases

  • No Cases Found

Listed below are those cases in which this Featured Case is cited. Click on the case name to see the full text of the citing case.

Citing Cases